Ayala-Cuellar Ana Patricia, Kang Ji-Houn, Jeung Eui-Bae, Choi Kyung-Chul
Laboratory of Biochemistry and Immunology, Republic of Korea.
Laboratory of Internal Medicine, Republic of Korea.
Biomol Ther (Seoul). 2019 Jan 1;27(1):25-33. doi: 10.4062/biomolther.2017.260.
Mesenchymal stem cells are classified as multipotent stem cells, due to their capability to transdifferentiate into various lineages that develop from mesoderm. Their popular appeal as cell-based therapy was initially based on the idea of their ability to restore tissue because of their differentiation potential ; however, the lack of evidence of their differentiation to target cells led researchers to focus on their secreted trophic factors and their role as potential powerhouses on regulation of factors under different immunological environments and recover homeostasis. To date there are more than 800 clinical trials on humans related to MSCs as therapy, not to mention that in animals is actively being applied as therapeutic resource, though it has not been officially approved as one. But just as how results from clinical trials are important, so is to reveal the biological mechanisms involved on how these cells exert their healing properties to further enhance the application of MSCs on potential patients. In this review, we describe characteristics of MSCs, evaluate their benefits as tissue regenerative therapy and combination therapy, as well as their immunological properties, activation of MSCs that dictate their secreted factors, interactions with other immune cells, such as T cells and possible mechanisms and pathways involved in these interactions.
间充质干细胞被归类为多能干细胞,因为它们能够转分化为从中胚层发育而来的各种谱系。它们作为基于细胞的疗法广受欢迎,最初是基于其分化潜能能够修复组织的想法;然而,缺乏它们向靶细胞分化的证据,这使得研究人员将重点放在它们分泌的营养因子以及它们在不同免疫环境下作为调节因子的潜在强大作用以及恢复体内平衡方面。迄今为止,有800多项关于间充质干细胞作为治疗手段用于人类的临床试验,更不用说在动物身上它正被积极用作治疗资源,尽管它尚未被正式批准为一种治疗方法。但正如临床试验结果很重要一样,揭示这些细胞发挥其愈合特性的生物学机制以进一步提高间充质干细胞在潜在患者中的应用也很重要。在这篇综述中,我们描述了间充质干细胞的特征,评估了它们作为组织再生疗法和联合疗法的益处,以及它们的免疫特性、决定其分泌因子的间充质干细胞的激活、与其他免疫细胞(如T细胞)的相互作用以及这些相互作用中涉及的可能机制和途径。